The Centers for Medicare and Medicaid Services will be implementing prior authorization requirements for certain traditional ...

Biocon Biologics Receives MHRA UK Approval for Vevzuo® and Evfraxy®, Denosumab Biosimilars Bengaluru, Karnataka, India, July 7, 2025  Biocon Biologics Ltd (BBL), a fully integrated global biosimilars ...

A 74-year-old man sustained a T12 compression fracture after being rear-ended by an unlicensed driver in Henrico County.

Biocon Biologics receives marketing authorizations for Vevzuo and Evfraxy biosimilars for bone-related diseases in the UK.

New Delhi: Biocon Ltd on Monday said its arm Biocon Biologics Ltd has received marketing authorisations from the Medicines ...

Biocon Biologics receives UK MHRA approval for Vevzuo & Evfraxy, biosimilars of Denosumab, to treat bone diseases in adults & ...

Biocon Biologics announced that the Medicines and Healthcare products Regulatory Agency (MHRA) granted marketing authorisations in the United Kingdom (UK) for Vevzuo and Evfraxy, biosimilars of ...

Shrinking height in older adults is due to ageing. It could mean serious spinal fractures caused by bone loss over time.

Clinical studies have demonstrated that both biosimilars are comparable in safety and efficacy to the reference product, the ...

Biocon said that Biocon Biologics has received marketing authorisations from UK Medicines and Healthcare products Regulatory Agency for Vevzuo and Evfraxy, biosimilars of Denosumab.

Skeletal system metastases are the third most common type of metastases in patients with cancer, and metastatic epidural spinal cord compression (MESCC) is estimated to occur in 5–10% of all ...

Introduction Vertebral compression fractures (VCFs) affect more than 700 000 individuals in the USA every year and are most often secondary to osteoporosis or low bone mass. 1 2 The medical cost of ...